Results 221 to 230 of about 182,488 (255)

Suspected Gluteal Epithelioid Sarcoma Complicated by Secondary Infection and Sciatic Neuropathy: A Case Report

Clinical Case Reports, Volume 14, Issue 11, November 2026.
ABSTRACT Secondary infection can coexist with and obscure an underlying soft‐tissue sarcoma. A deep mass that persists or progresses despite drainage and appropriate antibiotics, especially with progressive neurological deficit, warrants image‐guided core biopsy and sarcoma‐center referral before further surgery.
Baraa Nassar, Rawan Omar Nayfeh, Eman Sheikhasan, Saif Khaled Abdalhadi Azzam, Mohammedali Atef Abumayyala   +4 more
wiley   +1 more source

Therapeutic Drug Monitoring of Vancomycin Based on Ratio of Area under the Curve to Minimum Inhibitory Concentration: A Quality Improvement Project. [PDF]

Can J Hosp Pharm
McDougal K, Paquette V, Kendrick J, Carr R.   +3 more
europepmc   +1 more source

A Case of Disseminated Encephalitozoon cuniculi in a Lung Transplant Recipient: Microsporidiosis in the Era of Molecular Diagnostics

Transplant Infectious Disease, EarlyView.
Lee S. Gottesdiener, Clare DeLaurentis, Marcus R. Pereira   +2 more
wiley   +1 more source

Bacterial Agents and Their Multidrug‐Resistance Profile Among Patients Suspected of Bacterial Infections in Hakim Gizaw Hospital, Debre Berhan, Ethiopia: A Cross‐Sectional Study

Health Science Reports, Volume 9, Issue 11, November 2026.
ABSTRACT Background and Aims Antimicrobial resistance is a global threat. Bacteria showed higher resistance in Ethiopia, and up‐to‐date data on it is urgently required for effective interventions. This study aimed to determine occurrence of multi‐drug‐resistant (MDR) bacterial isolates among patients presented to Hakim Gizaw Hospital (HGH).
Tizazu Zenebe Zelelie, Ermias Endewunetu, Yosef Temesgen, Demissew Shenkute Gebreyes, Zenawork Sahile, Biniam Mekonnen, Getachew Bizuneh, Asrat Berihun, Berhanu Yitayew   +8 more
wiley   +1 more source

Molecular characterization of vancomycin-resistant <i>Enterococcus faecium</i> and identification of a clinical strain co-harboring the G2505A mutation associated with linezolid resistance from a tertiary hospital in China. [PDF]

Microbiol Spectr
Suo N, Wang Y, Chen C, Li H, Yi N, Li X, Liu C, Wang W.   +7 more
europepmc   +1 more source

Trough concentrations of 10-15 mg/L of vancomycin are generally sufficient to achieve pharmacodynamic targets, whereas higher troughs can result in unnecessary nephrotoxicity: we respectfully disagree. [PDF]

Crit Care
Honoré PM, Benkaddour Y, Muscato CY.
europepmc   +1 more source

Comparison of Vancomycin Trough Concentrations in Pediatric Patients with and without Sickle Cell Disease: A Cohort Study in Saudi Children. [PDF]

J Pediatr Pharmacol Ther
Azam S, Alrashed K, Almijmaj M, Almaa Z, Hago FE, Bakri AY.   +5 more
europepmc   +1 more source

<i>Zanthoxylum beecheyanum</i> enhances vancomycin activity and inhibits biofilm formation in resistant <i>staphylococcus aureus</i>. [PDF]

Front Pharmacol
Idrees A, Abbas IS, Li J, Hussein M, Velkov T.   +4 more
europepmc   +1 more source

The efflux pump QacA mediates the transition to vancomycin heteroresistance in sequence type 5 methicillin-resistant <i>Staphylococcus aureus</i> via membrane lipid reprogramming. [PDF]

Emerg Microbes Infect
Xi L, Bian Q, Yang P, Wu H, Shi X, Guo B, Fan Y, Zhang J.   +7 more
europepmc   +1 more source